Previous 10 | Next 10 |
David Einhorn's 13F stock portfolio value increased from $1.49B to $1.75B this quarter. Greenlight increased Capri Holdings, ODP Group, Livanova, & Victoria’s Secret while reducing Twitter, Concentrix, & EchoStar. They also added Global Payments while dropping AerCap an...
Study to evaluate effectiveness of hypoglossal nerve stimulation LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the first patient implanted in the investigational device exemption (IDE) clinical study, “Treatin...
LivaNova PLC (LIVN) Q4 2021 Earnings Conference Call February 23, 2022, 8:00 AM ET Company Participants Damien McDonald – Chief Executive Officer Matthew Dodds – Senior Vice President of Corporate Development Alex Shvartsburg – Chief Financial Officer Conference Call Part...
The following slide deck was published by LivaNova PLC in conjunction with their 2021 Q4 earnings call. For further details see: LivaNova PLC 2021 Q4 - Results - Earnings Call Presentation
LivaNova PLC press release (NASDAQ:LIVN): Q4 Non-GAAP EPS of $0.57 beats by $0.05. Revenue of $270.1M (+0.2% Y/Y) beats by $2.9M. 2022 Guidance: The company expects worldwide net sales for full-year 2022 to grow between 3 and 5 percent on a constant-currency basis vs consensus of$1....
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2021. For the fourth quarter of 2021, worldwide sales from continuing operations were $270.1 million, an increase of 0.2 p...
As per our first article, DTD remains incredibly attractive, even with conservative prevalence figures. The whole neuromodulation opportunity renders the company a potential growth engine. Three major trials are underway for three unmet medical needs which will rocket profile to o...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth-quarter and full-year 2021 results on Wednesday, February 23, 2022 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its fourth-...
Harris Associates’ 13F portfolio value decreased from $62.80B to $62.77B this quarter. They increased Fiserv, Humana, and Alibaba while decreasing CNH Industrial, Liberty Global, and Automatic Data Processing. The top three positions are Alphabet, Bank of America, and Chart...
The following slide deck was published by LivaNova PLC in conjunction with this event. For further details see: LivaNova (LIVN) Investor Day 2021 Presentation - Slideshow
News, Short Squeeze, Breakout and More Instantly...
2024-06-23 00:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2024 results prior to the call. ...
2024-06-06 11:00:14 ET Rick Wise from Stifel Nicolaus issued a price target of $70.00 for LIVN on 2024-06-06 09:52:00. The adjusted price target was set to $70.00. At the time of the announcement, LIVN was trading at $53.16. The overall price target consensus is at $69.5...